Phibro Animal Health (PAHC) Misses Q1 EPS by 2c, Revenues Miss; FY18 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
November 6, 2018 4:15 PM ESTTEANECK, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its first quarter ended September 30, 2018, and presented updated financial guidance for the fiscal year.
Highlights for the September 2018 quarter (compared to the September 2017 quarter)
Net sales of $200 million, an increase of $7 million, or 3%Net income of $16 million, an increase of 3%Diluted EPS of $0.40, an increase of $0.01, or 3%Adjusted EBITDA of $30 million, even with the prior yearAdjusted diluted EPS of $0.39, an increase of $0.01, or... More